Kwality Pharmaceuticals Limited

BSE:539997 Stock Report

Market Cap: ₹9.3b

Kwality Pharmaceuticals Past Earnings Performance

Past criteria checks 5/6

Kwality Pharmaceuticals has been growing earnings at an average annual rate of 5.4%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 9.6% per year. Kwality Pharmaceuticals's return on equity is 12%, and it has net margins of 8.5%.

Key information

5.4%

Earnings growth rate

5.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate9.6%
Return on equity12.0%
Net Margin8.5%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Kwality Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:539997 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,4022903710
30 Jun 243,1982673470
31 Mar 243,0722383260
31 Dec 232,8401203160
30 Sep 232,6211153170
30 Jun 232,4831433160
31 Mar 232,5101943010
31 Dec 222,4803692810
30 Sep 222,7994562620
30 Jun 224,0629622220
31 Mar 224,5621,2002030
31 Dec 214,6341,1391910
30 Sep 214,4731,0221790
30 Jun 213,2324601670
31 Mar 212,6311511600
31 Dec 202,2661311460
30 Sep 201,8971101620
30 Jun 201,661971580
31 Mar 201,425831240
31 Dec 191,550831190
30 Sep 191,675821110
30 Jun 191,67179990
31 Mar 191,66776900
31 Dec 181,57864770
30 Sep 181,48853640
30 Jun 181,43449610
31 Mar 181,38045570
31 Dec 171,26647540
30 Sep 171,14449500
30 Jun 171,06941470
31 Mar 1799334440
31 Dec 1693328400
30 Sep 1684022350
30 Jun 1679219310
31 Mar 1674416280
31 Mar 155268210
31 Mar 145979180

Quality Earnings: 539997 has high quality earnings.

Growing Profit Margin: 539997's current net profit margins (8.5%) are higher than last year (4.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 539997's earnings have grown by 5.4% per year over the past 5 years.

Accelerating Growth: 539997's earnings growth over the past year (152.6%) exceeds its 5-year average (5.4% per year).

Earnings vs Industry: 539997 earnings growth over the past year (152.6%) exceeded the Pharmaceuticals industry 20.4%.

Return on Equity

High ROE: 539997's Return on Equity (12%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 17:31
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kwality Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution